Insider · CIK 0001463151

Levine James E.

Reports to the SEC for 4 companies · SYDNEY

sec.gov

Transactions

Companies

Filings

CIK

0001463151

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-19	KZIAKAZIA THERAPEUTICS LTD · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2025-03-11	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+333K sh	—	—	1,295,117
2024-12-18	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,400 sh	$5.00	+$12K	67,716
2024-12-17	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,752 sh	$5.42	+$14.9K	65,316
2024-12-16	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,564 sh	$3.83	+$9,820.12	62,564
2024-03-07	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+205K sh	—	—	962,496
2023-03-15	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+197K sh	—	—	757,488
2022-09-16	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+30K sh	$1.56	+$46.7K	60,000
2022-03-09	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+170K sh	—	—	560,016
2021-09-10	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$6.62	+$33.1K	5,000
2021-09-10	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$6.75	+$33.8K	10,000
2021-09-10	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$6.38	+$63.8K	20,000
2021-09-10	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$6.35	+$31.8K	25,000
2021-09-10	CRDFCardiff Oncology, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$6.32	+$31.6K	30,000
2021-07-12	CRDFCardiff Oncology, Inc. · Common StockA Award	Chief Financial Officer	AAward	+390K sh	—	—	390,000
2021-03-17	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+130K sh	—	—	130,000
2020-11-10	CDTXCidara Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+50K sh	$2.01	+$101K	50,000
2020-03-19	CDTXCidara Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+25K sh	—	—	61,891
2020-03-19	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+110K sh	—	—	110,000
2020-01-28	CDTXCidara Therapeutics, Inc.X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	+6,891 sh	$2.51	+$17.3K	211,891
2020-01-28	CDTXCidara Therapeutics, Inc. · Subscription Rights (right to buy)X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	−6,891 sh	—	—	0
2019-09-24	CDTXCidara Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+30K sh	$1.91	+$57.2K	30,000
2019-09-24	CDTXCidara Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+30K sh	$1.91	+$57.2K	205,000
2018-12-03	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2013-10-31	VERENIUM CORPD Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−109K sh	$4.00	−$437K	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−24.1K sh	—	—	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−84.6K sh	—	—	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−34.8K sh	—	—	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−20K sh	—	—	0
2013-10-31	VERENIUM CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−13.1K sh	—	—	0
2013-10-31	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−10.9K sh	—	—	0
2013-10-31	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−444 sh	—	—	0
2013-10-31	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−130K sh	—	—	0
2013-10-31	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−20.8K sh	—	—	0
2013-10-31	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−16.9K sh	—	—	0
2013-08-01	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+24.1K sh	—	—	24,063
2013-08-01	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+10.9K sh	—	—	10,937
2012-08-02	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+13.1K sh	$4.23	+$55.5K	13,125
2012-08-02	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+16.9K sh	$4.23	+$71.4K	16,875
2012-05-15	VERENIUM CORPP Purchase	Director, President & CEO	PPurchase	+4,994 sh	$3.65	+$18.2K	109,166
2011-08-25	VERENIUM CORPP Purchase	Director, President & CEO	PPurchase	+25K sh	$3.18	+$79.5K	104,172
2011-08-12	VERENIUM CORPP Purchase	Director, President & CEO	PPurchase	+25K sh	$1.69	+$42.3K	79,172
2011-02-24	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+34.8K sh	—	—	34,796
2011-02-24	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+130K sh	—	—	129,695
2010-09-07	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+84.6K sh	—	—	84,556
2010-09-07	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+444 sh	—	—	444
2010-08-16	VERENIUM CORPP Purchase	Director, President & CEO	PPurchase	+25.2K sh	$2.51	+$63.1K	54,172
2010-08-13	VERENIUM CORPP Purchase	Director, President & CEO	PPurchase	+24.9K sh	$2.50	+$62.1K	29,022
2009-12-11	VERENIUM CORPEmployee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+20K sh	$4.12	+$82.4K	20,000
2009-11-12	VERENIUM CORPNon-Qualified Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+20.8K sh	—	—	20,833

Recent filings

Accepted (ET)
Jun 234
Levine James E.0001213900-26-071231
SEC(opens sec.gov)
Mar 134
Levine James E.0000950170-25-038708
SEC(opens sec.gov)
Dec 184
Levine James E.0000950170-24-137938
SEC(opens sec.gov)
Mar 74
Levine James E.0001628280-24-009748
SEC(opens sec.gov)
Mar 164
Levine James E.0001628280-23-008356
SEC(opens sec.gov)
Sep 194
Levine James E.0001628280-22-025099
SEC(opens sec.gov)
Mar 104
Levine James E.0001628280-22-005792
SEC(opens sec.gov)
Sep 134
Levine James E.0001628280-21-018433
SEC(opens sec.gov)
Jul 124
Levine James E.0001628280-21-013754
SEC(opens sec.gov)
Mar 194
Levine James E.0001610618-21-000024
SEC(opens sec.gov)
Nov 124
Levine James E.0001209191-20-057806
SEC(opens sec.gov)
Mar 234
Levine James E.0001209191-20-020747
SEC(opens sec.gov)
Mar 234/A
Levine James E.0001209191-20-020744
SEC(opens sec.gov)

Companies

Address

THREE INTERNATIONAL TOWERS, LEVEL 24 300 BARANGAROO AVENUE

SYDNEY, 2000